American College of Cardiology

News Releases - Tuesday, April 1

Contact:
Amy Murphy, amurphy@acc.org

1 p.m.

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk Coronary Artery Bypass Graft (CABG) Surgery: Primary Results of the MEND-CABG II Trial

Results of a Multicenter Randomized Double-Blind Placebo-Controlled Study to Assess the Benefit and Safety of Rosiglitazone in Preventing Atherosclerosis Progression After Coronary Artery Bypass Surgery in Type 2 Diabetes

Results of the ON-TIME 2 Trial: Prehospital Tirofiban in STEMI

Efficacy and Safety of Continuous Aortic Flow Augmentation in Patients Hospitalized With Acute Decompensated Heart Failure: Results of the MOMENTUM Trial

Effects of Rolofylline, a New Adenosine A1 Receptor Antagonist, on Symptoms, Renal Function and Outcomes in Patients With Acute Heart Failure: Results of the PROTECT Pilot Study

Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Inotropic Agent With Lusitropic Properties, in Acute Heart Failure Syndromes (HORIZON-HF)

8:30 a.m.

Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease (STRADIVARIUS)

Results of the Home Automatic External Defibrillator Trial (HAT)

12-Month Results of the REVERSE Study

Long-Term Cardiac Arrhythmias Recorded by an Insertable Loop Recorder in Patients With Reduced Ejection Fraction After Acute Myocardial Infarction: The CARISMA Study

The TRENDS Study: Is There a Critical Value of Daily Atrial Tachyarrhythmia Burden From Device Diagnostics That Raises Stroke Risk?

Societal Cost and Cost to Medicare for Enhanced Monitoring Using a Computer-Based Telephonic Monitoring System in Older Patients With Heart Failure: The Heart Failure Home Care Trial